With vague symptoms and no screening test, ovarian cancer can be deadly. According to NCI’s Surveillance, Epidemiology and End Results program, 20,890 people will receive an ovarian cancer diagnosis in 2025 and of these, more than half will learn that their ovarian cancer has spread to distant organs.
FDA has withdrawn a proposed rule that called for standardized testing for detecting and identifying asbestos in talc-containing cosmetic products.
